Whether ahead of their time, truly bizarre, or just plain doomed, it’s certainly interesting to see companies go completely ...
These launches belong to what Oelrich called “must-win battles” at Bayer as Xarelto loss of exclusivity reaches “full swing” ...
Chemical company Monsanto — owned by Bayer — was found liable this week by a jury for harm caused to students and parents at ...
Bayer expects its pharmaceutical business to return to growth in 2027 as the launch new therapies is expected to offset ...
In a bold move to restore profitability, Bayer CEO Bill Anderson cut out most of the company’s management roles last year.
Bayer's projected earnings decline and litigation pressures affect its outlook. Find out why BAYRY stock might face ...
The results suggest Bayer’s elinzanetant may help a broader group of women with vasomotor symptoms, which are associated with ...